Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cerecor Inc (CERC)

Cerecor Inc (CERC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cerecor Inc 540 Gaither Road Suite 400 Rockville MD 20850 USA

www.cerecor.com P: 410-522-8707

Description:

Cerecor, Inc. is a biopharmaceutical company which focuses on the development of drugs for the treatment of patients with neurological and psychiatric disorders. The company's portfolio of clinical and preclinical candidates consists of CERC-301, CERC-501 and CERC-406. CERC-301; adjunctive antidepressant for the treatment of patients with major depressive disorder; CERC-501, for co-occurring psychiatric and substance use disorders and CERC-406, for the treatment of residual cognitive impairment symptoms. Cerecor, Inc. is headquartered in Baltimore, Maryland.

Key Statistics

Overview:

Market Capitalization, $K 281,306
Shares Outstanding, K 96,009
Annual Sales, $ 6,700 K
Annual Net Income, $ -63,500 K
Last Quarter Sales, $ 3,360 K
Last Quarter Net Income, $ -17,110 K
60-Month Beta 1.44
% of Insider Shareholders 64.30%
% of Institutional Shareholders 62.84%
Float, K 34,275
% Float 35.70%

Growth:

1-Year Return 11.83%
3-Year Return -39.34%
5-Year Return -25.06%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 87.90%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 08/05/21
Earnings Per Share ttm -0.66
EPS Growth vs. Prev Qtr 43.75%
EPS Growth vs. Prev Year -20.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CERC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -261.82%
Return-on-Assets % -133.96%
Profit Margin % -947.76%
Debt/Equity 0.79
Price/Sales 42.71
Price/Cash Flow N/A
Price/Book 13.03
Book Value/Share 0.22
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar